FFA
KNSA icon

Farther Finance Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Farther Finance Advisors’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Buy
1,617
+81
+5% +$4.2K ﹤0.01% 2685
2026
Q1 		$73.9K Sell
1,536
-18
-1% -$797 ﹤0.01% 2732
2025
Q4 		$64.1K Buy
1,554
+196
+14% +$7.86K ﹤0.01% 2649
2025
Q3 		$52.7K Buy
1,358
+1,159
+582% +$37.7K ﹤0.01% 2406
2025
Q2 		$5.51K Hold
199
– – ﹤0.01% 3323
2025
Q1 		$4.33K Hold
199
– – ﹤0.01% 3123
2024
Q4 		$3.94K Hold
199
– – ﹤0.01% 2758
2024
Q3 		$4.97K Hold
199
– – ﹤0.01% 2650
2024
Q2 		$3.58K Buy
+199
New +$3.73K ﹤0.01% 2543

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Farther Finance Advisors's KNSA Position: Q2 2026 in Review

Farther Finance Advisors increased its Kiniksa Pharmaceuticals (KNSA) stake by 5.3% in Q2 2026, buying an estimated $4.2K and bringing the position to 1,617 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #2685.

Farther Finance Advisors first reported a position in KNSA in Q2 2024 and has held it in 9 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Farther Finance Advisors held 1,617 shares of Kiniksa Pharmaceuticals worth $102K as of Q2 2026.
  • Farther Finance Advisors bought 81 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $4.2K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2685 holding.
  • Farther Finance Advisors first reported a position in Kiniksa Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.